New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells

Hepatology. 2010 Jan;51(1):344-5; author reply 345. doi: 10.1002/hep.23378.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Atorvastatin
  • Hepacivirus / drug effects*
  • Hepatitis C / drug therapy*
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Induced Pluripotent Stem Cells
  • Pyrroles / therapeutic use
  • Quinolines / therapeutic use

Substances

  • Antiviral Agents
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Quinolines
  • Atorvastatin
  • pitavastatin